Cardiac Regenerative Therapy - Koninckx, Remco;Hensen, Karen;Hendrikx, Marc
38,99 €
inkl. MwSt.
Versandkostenfrei*
Versandfertig in 6-10 Tagen
payback
19 °P sammeln
  • Broschiertes Buch

A myocardial infarction is characterized by a massive loss of cardiomyocytes and reduces the function of the heart tremendously. Several pharmacological drugs, e.g. digoxin, diuretics, and surgical therapies, e.g. coronary artery bypass graft (CABG) and ventricular restoration procedures were developed over the years. These therapies and treatments moderately improved the quality of life and increased life expectancy, but are no cure for heart failure. A promising approach for the near future to repair the injured heart is transplantation of stem cells. In this book, different stem cell types…mehr

Andere Kunden interessierten sich auch für
Produktbeschreibung
A myocardial infarction is characterized by a massive loss of cardiomyocytes and reduces the function of the heart tremendously. Several pharmacological drugs, e.g. digoxin, diuretics, and surgical therapies, e.g. coronary artery bypass graft (CABG) and ventricular restoration procedures were developed over the years. These therapies and treatments moderately improved the quality of life and increased life expectancy, but are no cure for heart failure. A promising approach for the near future to repair the injured heart is transplantation of stem cells. In this book, different stem cell types are thoroughly analysed for their cardiomyogenic differentiation capacities and therefore their clinical potential to compensate for the massive loss of cardiomyocytes.
Autorenporträt
This work is a realization between the Laboratory of Experimental Hematology and the Department of Cardiothoracic Surgery of the Jessa hospital, Hasselt, Belgium. Prof.dr. Jean-Luc Rummens and prof.dr. Marc Hendrikx started this collaboration already in 2001. In 2004 and 2006, dr. Karen Hensen and dr. Remco Koninckx respectively joined this team.